Inhibrx Biosciences, Inc.INBXNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.09
Net Income/Share$-10.02
Operating CF/Share$-9.26
Free CF/Share$-9.27
Cash/Share$9.89
Book Value/Share$2.38
Tangible Book/Share$2.38
Equity/Share$2.38
Interest Debt/Share$1.03
CapEx/Share$0.00
Dividend/Share$0.00
Valuation
Market Cap$1.20B
Enterprise Value$1.05B
P/E Ratio-8.21P/S Ratio854.24P/OCF Ratio-8.88
P/FCF Ratio-8.34
P/B Ratio34.56P/TB Ratio34.56
EV/Sales749.88EV/EBITDA-7.32
Graham Valuation
Graham Number--
Graham Net-Net$0.84
Profitability
Earnings Yield-12.19%FCF Yield-11.99%ROE-186.06%ROIC-107.16%Return on Tangible Assets-87.39%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-0.03%
CapEx/Revenue3.36%
CapEx/Depreciation0.02
SBC/Revenue812.64%
SG&A/Revenue2079.07%
R&D/Revenue8605.14%
Liquidity & Solvency
Debt/Equity0.19Debt/Assets0.04Debt/Market Cap0.01
Net Debt/EBITDA1.02
Current Ratio4.49Interest Coverage-17.09xIncome Quality0.92Efficiency
Days Sales Outstanding218 days
Days Payables Outstanding948 days
Days Inventory0 days
Receivables Turnover1.67x
Payables Turnover0.39x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$36.83M
Working Capital$125.44M
Invested Capital$135.75M
Intangibles/Assets0.00%